Research Paper Volume 13, Issue 6 pp 8975—8988

PARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survival

Efficacy of each PARPi in breast and ovarian cancer patients with BRCAm.

Figure 4. Efficacy of each PARPi in breast and ovarian cancer patients with BRCAm.